Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Thomas Flaten is an analyst at Lake Street. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/24/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/20/2025 | OPTN | Buy Now | OptiNose | $9.19 | -2.07% | Thomas Flaten35% | $17 → $9 | Downgrade | Buy → Hold | Get Alert |
| 03/10/2025 | CKPT | Buy Now | Checkpoint Therapeutics | $4.06 | 0.99% | Thomas Flaten35% | $7 → $4.1 | Downgrade | Buy → Hold | Get Alert |
| 03/07/2025 | AQST | Buy Now | Aquestive Therapeutics | $3.26 | 145.4% | Thomas Flaten35% | $10 → $8 | Maintains | Buy | Get Alert |
| 02/04/2025 | EVAX | Buy Now | Evaxion Biotech | $1.88 | 219.15% | Thomas Flaten35% | $35 → $6 | Maintains | Buy | Get Alert |
| 01/16/2025 | OPTN | Buy Now | OptiNose | $9.19 | 84.98% | Thomas Flaten35% | $45 → $17 | Maintains | Buy | Get Alert |
| 01/08/2025 | PSNL | Buy Now | Personalis | $3.74 | 140.64% | Thomas Flaten35% | $7 → $9 | Maintains | Buy | Get Alert |
| 12/16/2024 | CKPT | Buy Now | Checkpoint Therapeutics | $4.06 | 72.41% | Thomas Flaten35% | $4 → $7 | Maintains | Buy | Get Alert |
| 11/05/2024 | CSTL | Buy Now | Castle Biosciences | $20.89 | 91.43% | Thomas Flaten35% | $34 → $40 | Maintains | Buy | Get Alert |
| 09/06/2024 | DERM | Buy Now | Journey Medical | $5.97 | 50.75% | Thomas Flaten35% | → $9 | Initiates | → Buy | Get Alert |
| 05/15/2024 | OPTN | Buy Now | OptiNose | $9.19 | -67.36% | Thomas Flaten35% | $60 → $45 | Maintains | Buy | Get Alert |
| 04/30/2024 | PSNL | Buy Now | Personalis | $3.74 | 6.95% | Thomas Flaten35% | → $4 | Initiates | → Buy | Get Alert |
| 04/19/2024 | DMTK | Buy Now | DermTech | — | — | Thomas Flaten35% | → $0.63 | Downgrade | Buy → Hold | Get Alert |
| 03/18/2024 | OPTN | Buy Now | OptiNose | $9.19 | -56.47% | Thomas Flaten35% | $45 → $60 | Maintains | Buy | Get Alert |
| 03/12/2024 | ASRT | Buy Now | Assertio Holdings | $0.74 | 305.41% | Thomas Flaten35% | $4 → $3 | Maintains | Buy | Get Alert |
| 03/07/2024 | AQST | Buy Now | Aquestive Therapeutics | $3.26 | 145.4% | Thomas Flaten35% | $3 → $8 | Maintains | Buy | Get Alert |
| 03/05/2024 | ACHV | Buy Now | Achieve Life Sciences | $2.81 | 291.46% | Thomas Flaten35% | $19 → $11 | Maintains | Buy | Get Alert |
| 08/21/2023 | OPTN | Buy Now | OptiNose | $9.19 | -67.36% | Thomas Flaten35% | → $45 | Initiates | → Buy | Get Alert |
| 08/16/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $4.06 | 244.83% | Thomas Flaten35% | $16 → $14 | Maintains | Buy | Get Alert |
| 08/10/2023 | BTTX | Buy Now | Better Therapeutics | $0.00 | 749900% | Thomas Flaten35% | $5 → $3 | Maintains | Buy | Get Alert |
| 08/09/2023 | BLFS | Buy Now | BioLife Solns | $25.64 | -2.5% | Thomas Flaten35% | $34 → $25 | Maintains | Buy | Get Alert |
| 07/07/2023 | CSTL | Buy Now | Castle Biosciences | $20.89 | 53.15% | Thomas Flaten35% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | CSTL | Buy Now | Castle Biosciences | $20.89 | 53.15% | Thomas Flaten35% | $41 → $32 | Maintains | Buy | Get Alert |
| 05/31/2023 | ACHV | Buy Now | Achieve Life Sciences | $2.81 | 576.16% | Thomas Flaten35% | $22 → $19 | Maintains | Buy | Get Alert |
| 05/30/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $4.06 | 294.09% | Thomas Flaten35% | $22 → $16 | Maintains | Buy | Get Alert |
| 05/10/2023 | ACHV | Buy Now | Achieve Life Sciences | $2.81 | 682.92% | Thomas Flaten35% | → $22 | Maintains | Buy | Get Alert |
| 05/10/2023 | ASRT | Buy Now | Assertio Holdings | $0.74 | 1116.22% | Thomas Flaten35% | $8 → $9 | Maintains | Buy | Get Alert |
| 04/14/2023 | BTTX | Buy Now | Better Therapeutics | $0.00 | 1249900% | Thomas Flaten35% | $6 → $5 | Maintains | Buy | Get Alert |
| 04/04/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $4.06 | 441.87% | Thomas Flaten35% | $32 → $22 | Maintains | Buy | Get Alert |
| 03/31/2023 | EVAX | Buy Now | Evaxion Biotech | $1.88 | 272.34% | Thomas Flaten35% | $1800 → $700 | Maintains | Buy | Get Alert |
| 12/01/2022 | OCX | Buy Now | OncoCyte | $3.54 | -85.87% | Thomas Flaten35% | $60 → $10 | Downgrade | Buy → Hold | Get Alert |
| 11/17/2022 | ENSC | Buy Now | Ensysce Biosciences | $3.80 | 110.53% | Thomas Flaten35% | $14400 → $1440 | Maintains | Buy | Get Alert |
| 11/07/2022 | ASRT | Buy Now | Assertio Holdings | $0.74 | 845.95% | Thomas Flaten35% | → $7 | Initiates | → Buy | Get Alert |
| 08/11/2022 | OCX | Buy Now | OncoCyte | $3.54 | -15.25% | Thomas Flaten35% | $120 → $60 | Maintains | Buy | Get Alert |
| 07/07/2022 | DMAC | Buy Now | DiaMedica Therapeutics | $4.98 | 60.64% | Thomas Flaten35% | $14 → $8 | Maintains | Buy | Get Alert |
| 05/13/2022 | BBI | Buy Now | Brickell Biotech | — | — | Thomas Flaten35% | — | Downgrade | Buy → Hold | Get Alert |
| 03/11/2022 | OCX | Buy Now | OncoCyte | $3.54 | 69.51% | Thomas Flaten35% | $220 → $120 | Maintains | Buy | Get Alert |
| 03/01/2022 | CSTL | Buy Now | Castle Biosciences | $20.89 | 201.51% | Thomas Flaten35% | $94 → $63 | Maintains | Buy | Get Alert |
| 11/30/2021 | ENSC | Buy Now | Ensysce Biosciences | $3.80 | 5.26% | Thomas Flaten35% | → $14400 | Initiates | → Buy | Get Alert |
| 04/30/2021 | CSTL | Buy Now | Castle Biosciences | $20.89 | 349.87% | Thomas Flaten35% | → $94 | Initiates | → Buy | Get Alert |
| 08/28/2020 | BBI | Buy Now | Brickell Biotech | — | — | Thomas Flaten35% | → $270 | Initiates | → Buy | Get Alert |
| 02/24/2020 | BLFS | Buy Now | BioLife Solns | $25.64 | -2.5% | Thomas Flaten35% | → $25 | Initiates | → Buy | Get Alert |
| 03/24/2016 | OCX | Buy Now | OncoCyte | $3.54 | — | Thomas Flaten35% | — | Initiates | → Buy | Get Alert |
